Picture of Genmab A/S logo

GMAB Genmab A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Earnings Poll: Genmab A/S  third quarter results due on November 6

Nov 5 (Reuters) - (All figures in US Dollars)

Genmab A/S GMAB.CO reports its third quarter results on November 6.

Year to date, Genmab A/S shares are up 24.92%.

Below is a table of quarterly and annual analyst estimates for results based on LSEG data.

Qtr. to September 2025No. of analystsMean Estimate
Revenue10991.17 million
Pre-tax profit6377.94 million
EPS84.64
EBIT8379.51 million
Net Profit7297.86 million
Year to December 2025No. of AnalystsMean Estimate
Revenue183.66 billion
Pre-tax profit151.36 billion
EPS1616.94
EBITDA131.38 billion
EBIT161.24 billion
Net Profit161.07 billion
Dividend120.00
Net Debt10-3.13 billion
Genmab A/S belongs to the OMX Copenhagen 20 Index. Please note that consensus estimates may be updated between publication of the poll and the report. This summary was auto generated on November 4 at 15:32. (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com, +48 58 7696600))

Recent news on Genmab A/S

See all news